Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sven Gläsker, Evelynn Vergauwen, Christian A Koch, Alexander Kutikov & Alexander O Vortmeyer. (2020) Von Hippel-Lindau Disease: Current Challenges and Future Prospects. OncoTargets and Therapy 13, pages 5669-5690.
Read now
Read now
Gigja Guðbrandsdottir, Karin M. Hjelle, Jannicke Frugård, Leif Bostad, Hans J. Aarstad & Christian Beisland. (2015) Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Scandinavian Journal of Urology 49:5, pages 388-394.
Read now
Read now
Roberto Scatena, Patrizia Bottoni, Alessandro Pontoglio, Lucia Mastrototaro & Bruno Giardina. (2008) Glycolytic enzyme inhibitors in cancer treatment. Expert Opinion on Investigational Drugs 17:10, pages 1533-1545.
Read now
Read now
Articles from other publishers (9)
Sandra Steffens, Astrid Köhler, Raphael Rudolph, Hendrik Eggers, Christoph Seidel, Martin Janssen, Gerd Wegener, Mark Schrader, Markus A Kuczyk & Andres J Schrader. (2012) Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer 12:1.
Crossref
Crossref
H Yang, K Zhao, Q Yu, X Wang, Y Song & R Li. (2012) Evaluation of Plasma and Tissue S100A4 Protein and mRNA Levels as Potential Markers of Metastasis and Prognosis in Clear Cell Renal Cell Carcinoma. Journal of International Medical Research 40:2, pages 475-485.
Crossref
Crossref
Steven C. Campbell & Brian R. Lane. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
1413
1474.e33
.
S P K Jagdev, W Gregory, N S Vasudev, P Harnden, S Sim, D Thompson, J Cartledge, P J Selby & R E Banks. (2010) Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. British Journal of Cancer 103:11, pages 1649-1656.
Crossref
Crossref
Jeremiah J. Morrissey, Amy N. London, Jingqin Luo & Evan D. Kharasch. (2010) Urinary Biomarkers for the Early Diagnosis of Kidney Cancer. Mayo Clinic Proceedings 85:5, pages 413-421.
Crossref
Crossref
Sergio Bracarda. (2009) Metastatic Renal Cell Carcinoma: Pathogenesis and the Current Medical Landscape. European Urology Supplements 8:10, pages 787-792.
Crossref
Crossref
Guo-Xia Tong, Woojin M Yu, Nike T Beaubier, Erin M Weeden, Diane Hamele-Bena, Mahesh M Mansukhani & Kathleen M O'Toole. (2009) Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Modern Pathology 22:9, pages 1218-1227.
Crossref
Crossref
Alexander S. Parker, Bradley C. Leibovich, Christine M. Lohse, Yuri Sheinin, Susan M. Kuntz, Jeanette E. Eckel‐Passow, Michael L. Blute & Eugene D. Kwon. (2009) Development and evaluation of BioScore. Cancer 115:10, pages 2092-2103.
Crossref
Crossref
Alexander D. Romaschin, Youssef Youssef, Tsz-fung F. Chow, K.W. Michael Siu, Leroi V. DeSouza, R. John Honey, Robert Stewart, Kenneth T. Pace & George M. Yousef. (2009) Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins. Biological Chemistry 390:2, pages 125-135.
Crossref
Crossref